East Bay company eyes first drug approval after decade-long journey

Ron Leuty
East Bay company eyes first drug approval after decade-long journey

The company has burned through $400 million, laid off employees and lost two Big Pharma partnerships, but now it is near an FDA drug approval for people with a debilitating bowel disorder.